Literature DB >> 7159928

Assembly of adenovirus major capsid protein is mediated by a nonvirion protein.

C L Cepko, P A Sharp.   

Abstract

The assembly of hexon, the major capsid protein of adenovirus, was investigated with the use of conformation-specific monoclonal antibodies. The hexon capsomere is a trimer of three identical monomers folded into a highly conserved and stable structure. The unique nature of this structure is indicated by the lack of common antigenic determinants between the capsomere and either monomeric or denatured hexon. The assembly of the trimer requires the action of a nonvirion protein, the 100K protein. The virus-encoded 100K protein forms a tight complex with hexon polypeptides. This 100K-hexon complex can form on the polyribosomes while hexon is a nascent chain. Exclusion chromatography revealed that the complex has a molecular weight of 800,000. The complex contains only pretrimer hexon; no mature hexon capsomeres can be found bound to 100K. Kinetic analysis of hexon trimerization and hexon-100K binding indicated that trimerization and the release of hexon from the complex occur concomitantly.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7159928     DOI: 10.1016/0092-8674(82)90134-9

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  38 in total

1.  Mechanism of scaffolding-directed virus assembly suggested by comparison of scaffolding-containing and scaffolding-lacking P22 procapsids.

Authors:  P A Thuman-Commike; B Greene; J A Malinski; M Burbea; A McGough; W Chiu; P E Prevelige
Journal:  Biophys J       Date:  1999-06       Impact factor: 4.033

2.  Switch from capsid protein import to adenovirus assembly by cleavage of nuclear transport signals.

Authors:  Harald Wodrich; Tinglu Guan; Gino Cingolani; Dan Von Seggern; Glen Nemerow; Larry Gerace
Journal:  EMBO J       Date:  2003-12-01       Impact factor: 11.598

3.  CRM1-dependent transport supports cytoplasmic accumulation of adenoviral early transcripts.

Authors:  Melanie Schmid; Ramon A Gonzalez; Thomas Dobner
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

4.  Structure of an archaeal virus capsid protein reveals a common ancestry to eukaryotic and bacterial viruses.

Authors:  Reza Khayat; Liang Tang; Eric T Larson; C Martin Lawrence; Mark Young; John E Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-15       Impact factor: 11.205

Review 5.  Current advances and future challenges in Adenoviral vector biology and targeting.

Authors:  Samuel K Campos; Michael A Barry
Journal:  Curr Gene Ther       Date:  2007-06       Impact factor: 4.391

6.  Adenovirus serotype 5 L4-22K and L4-33K proteins have distinct functions in regulating late gene expression.

Authors:  Susan J Morris; Keith N Leppard
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

7.  Identification of a suppressor mutation that improves the yields of hexon-modified adenovirus vectors.

Authors:  Joseph T Bruder; Ping Chen; Elena Semenova; Charlie A Thomas; Svetlana Konovalova; Greg Ekberg; Damodar Ettyreddy; Duncan McVey; Jason G Gall; C Richter King; Douglas E Brough
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

8.  The herpes simplex virus triplex protein, VP23, exists as a molten globule.

Authors:  M D Kirkitadze; P N Barlow; N C Price; S M Kelly; C J Boutell; F J Rixon; D A McClelland
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

9.  Amino acid exchanges in the putative nuclear export signal of adenovirus type 5 L4-100K severely reduce viral progeny due to effects on hexon biogenesis.

Authors:  Orkide O Koyuncu; Thomas Speiseder; Thomas Dobner; Melanie Schmid
Journal:  J Virol       Date:  2012-11-21       Impact factor: 5.103

10.  A novel domain in adenovirus L4-100K is required for stable binding and efficient inhibition of human granzyme B: possible interaction with a species-specific exosite.

Authors:  Felipe Andrade; Livia A Casciola-Rosen; Antony Rosen
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.